Botulinum toxin--new mechanisms, new therapeutic directions?
Chapple
Christopher
C
Patel
Anand
A
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D018856:Cystitis, Interstitial / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013577:Syndrome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000503:physiopathology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A